Navigation Links
cGMP Safe Deposit Facility from European Collection of Cell Cultures (ECACC)

ProductscGMP Safe Deposit Facility from European Collection of Cell Cultures (ECACC)
Company European Collection of Cell Cultures (ECACC)
Item cGMP Safe Deposit Facility
Price 
Description cGMP Safe Deposit Service

ECACC is able to accept cell lines produced according to the requirements of cGMP for cryo-storage. The cell lines must be accompanied by a certificate to confirm they have been produced in accordance with the requirements of cGMP and that they have been tested for freedom from mycoplasma, bacteria or fungi. What are the benefits of the cGMP Safe Deposit Service?

Second site storage:
The ECACC cGMP Safe Deposit Service enables customers to comply with the requirements of cGMP by providing secure second site storage. The service is not designed to be used as the sole or primary site of storage.
Monitoring: The cGMP dedicated storage tank is monitored continuously by a chart recorder linked to a telemetry alarm system. ECACC monitor cell lines stored in the same vessel are periodically resuscitated and cultured to further confirm that conditions favourable for preserving cell lines are maintained.

Storage Conditions:
Cell lines are stored in vapour phase above a liquid nitrogen reservoir. The ampoules are placed within an aluminium cryo-box that can hold up to 100 ampoules. The depositor can request to have separate cryo-boxes for each cell line deposited or multiple deposits in one cryo-box. Cryo-boxes are exclusive to each customer.
Facilities: The cGMP dedicated storage vessel is housed in a purpose built ultra low storage facility which is one of the largest liquid nitrogen repositories in Europe. The facility can accommodate 50 liquid nitrogen storage vessels each containing up to 25,000 ampoules.
Validation: The purpose built ultra low storage facility has been validated by Installation Qualification (IQ). The dedicated cGMP storage vessel has been subjected to a formal IQ/Operational Qualification (OQ)/Performance Qualification (PQ) validation exercise. The chart recorder has been tested to IQ/OQ.

Security:
The site benefits from the high level of security that applies to the Centre for Emergency Preparedness and Response, Health Protection Agency, Porton Down. Security staff are present on site 24 hours a day and access to the ultra low storage facility is restricted to authorised personnel only. All the inventory storage vessels are configured for automatic liquid nitrogen replenishment and each vessel is alarmed and monitored by an electronic telemetry system.

Info European Collection of Cell Cultures (ECACC) European Collection of Cell Cultures (ECACC)
United Kingdom
Customer Service: +44 (0) 1980 612684
Fax Number: +44 (0) 1980 611315
Web Site: http://www.ecacc.org.uk/
NOTE: Price information is approximate list price and actual prices may vary.

Related biology products :

1. Mouse Anti-Human Caspr2 Monoclonal Antibody, Unconjugated, Clone K67/25 from UC Davis/NINDS/NIMH NeuroMab Facility
2. Mouse Anti-Mouse BKBeta2 potassium channel Monoclonal Antibody, Unconjugated, Clone N53/32 from UC Davis/NINDS/NIMH NeuroMab Facility
3. The National Collection of Pathogenic Viruses (NCPV) from European Collection of Cell Cultures (ECACC)
4. CnC (Cn402-05) from European Collection of Cell Cultures (ECACC)
5. CAOSMC (C354-05) from European Collection of Cell Cultures (ECACC)
6. CnAOSMC (Cn354-05) from European Collection of Cell Cultures (ECACC)
7. PPAEC (P302-05) from European Collection of Cell Cultures (ECACC)
8. PPASMC (P352-05) from European Collection of Cell Cultures (ECACC)
9. HER2plus Control Slides from European Collection of Cell Cultures (ECACC)
10. BBMVEC (B840-05) from European Collection of Cell Cultures (ECACC)
11. BAOSMC (B354-05) from European Collection of Cell Cultures (ECACC)
dNTP Set from Invitrogen
StrepMAB-Immo coated microplate; 96 well from IBA GmbH
cAMP[125I] Direct SPA Screening Biotrak Assay from GE Healthcare, formerly Amersham Biosciences
GIBCO Leibovitz's L-15 Medium powder from Invitrogen
Biology Products:
(Date:11/4/2009)...wire/ -- Global Rainmakers, Inc., an intellectual ...ratory, today announced that the company has exite...ommercialize its suite of technologies designed to...s. ,, During the past four years, the company h...d deploy a series of core--but expandable--technol...
(Date:11/4/2009)...re/ -- Glencoe Software, Inc., the commercial arm ...m ( http://openmicroscopy.org ), is proud to ann...of Cell Biology,s exciting new project titled "The...d a $2.5M stimulus grant through the National Inst...am, as part of the American Reinvestment and Recov...
(Date:11/3/2009)...timate loner of the ocean, cruising thousands of m... has discovered that the sharks have maintained su...s of thousands of years the white sharks in the no... into a population genetically distinct from shark...large, highly mobile species," said Salvador Jorge...
Breaking Biology News(10 mins):Global Rainmakers Brings Cutting-Edge Biometric Security Products to Reality 2Global Rainmakers Brings Cutting-Edge Biometric Security Products to Reality 3Glencoe Software to Support the ASCB 'Stimulus Grant' to Build Virtual Image Library of the Cell 2Tags reveal white sharks have neighborhoods in the north Pacific, say Stanford researchers 2Tags reveal white sharks have neighborhoods in the north Pacific, say Stanford researchers 3Tags reveal white sharks have neighborhoods in the north Pacific, say Stanford researchers 4Reportlinker Adds Therapeutics for Memory and Cognition Disorders Report 56193 1Reportlinker Adds Therapeutics for Memory and Cognition Disorders Report 56193 2Reportlinker Adds Therapeutics for Memory and Cognition Disorders Report 56193 3Reportlinker Adds Therapeutics for Memory and Cognition Disorders Report 56193 4Reportlinker Adds Therapeutics for Memory and Cognition Disorders Report 56193 5Reportlinker Adds Therapeutics for Memory and Cognition Disorders Report 56193 6Reportlinker Adds Therapeutics for Memory and Cognition Disorders Report 56193 7Reportlinker Adds Therapeutics for Memory and Cognition Disorders Report 56193 8Reportlinker Adds Therapeutics for Memory and Cognition Disorders Report 56193 9Reportlinker Adds World Markets for Fermentation Ingredients Report 56190 1Reportlinker Adds World Markets for Fermentation Ingredients Report 56190 2Reportlinker Adds World Markets for Fermentation Ingredients Report 56190 3Reportlinker Adds World Markets for Fermentation Ingredients Report 56190 4Reportlinker Adds World Markets for Fermentation Ingredients Report 56190 5Reportlinker Adds World Markets for Fermentation Ingredients Report 56190 6Reportlinker Adds World Markets for Fermentation Ingredients Report 56190 7Reportlinker Adds World Markets for Fermentation Ingredients Report 56190 8Reportlinker Adds World Markets for Fermentation Ingredients Report 56190 9Reportlinker Adds World Markets for Fermentation Ingredients Report 56190 10Reportlinker Adds World Markets for Fermentation Ingredients Report 56190 11Reportlinker Adds World Markets for Fermentation Ingredients Report 56190 12Giant Eagle Pharmacy to Offer Customers in Pennsylvania a Dose of Economic Relief Through Free Antibiotics Program 56188 1Giant Eagle Pharmacy to Offer Customers in Pennsylvania a Dose of Economic Relief Through Free Antibiotics Program 56188 2Giant Eagle Pharmacy to Offer Customers in Pennsylvania a Dose of Economic Relief Through Free Antibiotics Program 56188 3
...ulder, CO, USA The December Geosphere , The Geol...ne. Topics include detailed data integration from ..., sedimentology, and paleontology, to study the so...million years ago; sedimentation in a piggyback ba...ange, Nevada; and a study of the South Balkan exte...
...LUMBIA, Mo. In the race for bioengineered crops, ...t leg in a multi-leg relay. Once the sequence is c...s to identify genes, functions. A draft sequence o...plete genome will be available soon. Taking the ne...erdisciplinary Plant Group researchers have demons...
...ientists at St. Jude Children,s Research Hospital ... type is so ready to change its identity that it r...rox1 to dissuade it. , The researchers showed th... is sufficient to reprogram a specialized type of ...n the absence of active Prox1, the LEC actually lo...
Other Biology News:December Geosphere media highlights 2December Geosphere media highlights 3Tool helps identify gene function in soybeans 2Reprogrammable cell type depends on a single gene to keep its identity 2
(Date:11/6/2009)...UINCY, Mass., Nov. 6 Myriant Techn... developer and manufacturer of renewable bio-chem...ed technology provider Uhde GmbH, one of the world...), announced an alliance for the engineering, proc...ased Succinic Acid plants based on renewable feeds...
(Date:11/6/2009)...ALGARY, Nov. 6 /PRNewswire-FirstCall/ - Oncolytics... or the "Company") today announced updated results...in patients with sarcomas metastatic to the lung i...ive Tissue Oncology Society Meeting held in Miami ...er presentation, entitled "A Phase II Study of Int...
(Date:11/5/2009)...AITHERSBURG, Md., Nov. 5 ... financial results for the third quarter ended Sep...6 million ($0.04 per share) for the three months e...$6.8 million ($0.08 per share) in the comparable q...r 30, 2009, GenVec,s net loss was $14.1 million ($...
(Date:11/5/2009)...ANCHO CORDOVA, Calif., Nov. 5 /PRNewswire-FirstCal...ing supplier of innovative products for processing...lts for the first quarter of fiscal 2010. ,, Fo...y reported revenues of $5.2 million, a 15 percent ...t quarter a year ago. The Company said the key con...
Breaking Biology Technology:Myriant Technologies LLC, Uhde Corporation of America and Uhde GmbH Announce Alliance for Engineering, Procurement & Construction of World Scale Renewable Succinic Acid Plants 2Myriant Technologies LLC, Uhde Corporation of America and Uhde GmbH Announce Alliance for Engineering, Procurement & Construction of World Scale Renewable Succinic Acid Plants 3Oncolytics Biotech(R) Inc. Collaborators Present Positive Phase II Sarcoma Trial Results at CTOS Annual Meeting 2Oncolytics Biotech(R) Inc. Collaborators Present Positive Phase II Sarcoma Trial Results at CTOS Annual Meeting 3GenVec Reports Third Quarter 2009 Financial Results 2GenVec Reports Third Quarter 2009 Financial Results 3GenVec Reports Third Quarter 2009 Financial Results 4GenVec Reports Third Quarter 2009 Financial Results 5GenVec Reports Third Quarter 2009 Financial Results 6ThermoGenesis Reports 15 Percent Increase in First Quarter Revenues; Improved Bottom Line 2ThermoGenesis Reports 15 Percent Increase in First Quarter Revenues; Improved Bottom Line 3ThermoGenesis Reports 15 Percent Increase in First Quarter Revenues; Improved Bottom Line 4ThermoGenesis Reports 15 Percent Increase in First Quarter Revenues; Improved Bottom Line 5ThermoGenesis Reports 15 Percent Increase in First Quarter Revenues; Improved Bottom Line 6ThermoGenesis Reports 15 Percent Increase in First Quarter Revenues; Improved Bottom Line 7ThermoGenesis Reports 15 Percent Increase in First Quarter Revenues; Improved Bottom Line 8